What is TDAC's market cap?

$209.79M, based on the Nov 6 close of $10.87.

What is TDAC's P/E ratio?

37.9× trailing-twelve-month earnings of $5.54M.

Does Translational Development Acquisition pay a dividend?

No regular cash dividend has been paid in the last year.

How much of TDAC is sold short?

2.0K shares, 0.0% of float, as of Oct 15, 2026.

What sector is TDAC in?

Financials, in the Blank Checks industry.

NASDAQ · TDACFinancialsBlank Checks

Translational Development Acquisition Corp. Ordinary Shares (TDAC)

$10.87+0.05%

Close Nov 6, 2026 · split-adjusted

Nov 6, 2026$10.87▲ 3.97% in range

Nov 6, 2025Low $10.41 · High $10.91Nov 6, 2026

What changed · written from our data

As of Nov 6, 2026

Translational Development Acquisition closed at $10.87 on Nov 6, up 0.05%, 0.4% below its highest close since Jun 13. Volume of 9.1K shares was 0.73× its 20-day average (below normal).

Split-adjusted performance: +0.4% over one month, +2.2% over six months.

Short interest was 2.0K shares at the Oct 15 settlement, down 76.8% from the prior report (0.0% of float, 1.0 days to cover).

Market cap$209.8M19.3M shares

Revenue · quarter$0.00—

Diluted EPS$0.04−42.9% YoY

P/E · TTM37.9×

Net margin—

Dividend yieldNone

Range since Jun 1310.41 – 10.91−0.4% from high

Volume9.1K0.73× 20-day avg

Volatility · 60d2.8%Annualised

Short % of float0.0%1.0 days to cover

Net cash-$1.0MCash $85.9K

Next earnings—Not scheduled

Split-adjusted performance

1W +0.4%1M +0.4%3M 0.0%6M +2.2%YTD +3.6%1Y —3Y —5Y −28.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Blank Checks

Percentile among 170 companies (100 = best)

6-month momentum76

Revenue growth—

Net margin—

Value (low P/E)69

Size30

Industry medians: 6-month return +1.8%, revenue growth −2.0%, net margin −70.6%, P/E 41.4×.

Short interest

Details →

Shares short2.0K−76.8% vs prior

Days to cover1.0Settled Oct 15

% of float0.0%

Short vol. 10d13.1%of daily volume

Closest peers by size in Blank Checks

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
TDACTranslational Development Acquisition	$10.87	+0.05%	+2.2%	—	—	37.9	$209.8M
MTAKMarket Technology Acquisition	$9.87	+0.10%	—	—	—	—	$209.4M	Compare
TVIVTexas Ventures Acquisition IV	$9.99	+0.40%	—	—	—	—	$207.3M	Compare
HAVAHarvard Ave Acquisition	$10.29	+0.10%	—	—	—	—	$212.9M	Compare
EGHAEGH Acquisition	$10.46	0.00%	+1.9%	—	—	—	$214.4M	Compare
WLIIWillow Lane Acquisition Corp. II	$10.16	0.00%	—	—	—	—	$204.7M	Compare
KTWOK2 Capital Acquisition	$10.10	0.00%	—	—	—	—	$202.4M	Compare
GSHRGesher Acquisition Corp. II	$10.64	+0.19%	—	—	—	—	$217.6M	Compare
BEBETGE Value Creative Solutions	$10.07	+0.10%	—	—	—	—	$201.4M	Compare

News about Translational Development Acquisition

All news →

No recent articles focused on Translational Development Acquisition.

Quick answers

What does Translational Development Acquisition do?: Translational Development Acquisition Corp is a newly organized blank check company.
What is TDAC's market cap?: $209.79M, based on the Nov 6 close of $10.87.
What is TDAC's P/E ratio?: 37.9× trailing-twelve-month earnings of $5.54M.
Does Translational Development Acquisition pay a dividend?: No regular cash dividend has been paid in the last year.
How much of TDAC is sold short?: 2.0K shares, 0.0% of float, as of Oct 15, 2026.
What sector is TDAC in?: Financials, in the Blank Checks industry.

About Translational Development Acquisition

Translational Development Acquisition Corp is a newly organized blank check company.

HQ: New York, NYListed Feb 13, 2025translational-development.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology